Reported revenues for fiscal 2024 increased just 0.2%, excluding the impact of foreign currency. Prestige Consumer Healthcare said performance was driven by strong international OTC segment performance and strong eye and ear care, GI and dermatological category sales in North America. That was partially offset by lower women’s health, cough and cold and analgesic category sales as well as by the company’s exit from private label.

For fiscal year 2024, reported revenues for the North American OTC segment were $958.3 million compared to $973.8 million the year prior. International OTC healthcare reported revenues were $167.1 million for the year, an increase of 8.5%.

In February, Insight Pharmaceuticals, part of Prestige Consumer Healthcare, voluntarily recalled two lots of Ting 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid at the consumer level due to elevated levels of benzene. The same issue had prompted recalls in 2023,  including one lot of Americaine 20% Benzocaine Topical Anesthetic Spray (announced in December), and two lots of Ting 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder (announced in November).

Tarrytown, NY
www.prestigebrands.com

Sales: $350 million

Fifty-five percent of women seek relaxation and stress-reducing benefits from their body-cleansing routines, and Prestige’s intimate care brand Summer’s Eve is making self-care easier than ever with a growing collection touted to deliver a luxurious experience to daily wellness and beauty practices.

In 2023, the leading feminine care brand added to its popular Spa Daily Intimate Beauty Collection—the Spa Renewing Wash and Spa Calming Cleansing Cloths, which combine daily cleanliness with elevated self-care.

The Summer’s Eve Daily Intimate Beauty Collection now includes a Spa Calming Luxurious Wash infused with chamomile fragrance and a new Spa Renewing Wash with jasmine fragrance. Both wash fragrances are blended with essential oils. The new Spa Renewing Wash is also showcased in luxe gold packaging, making it easy to spot on the shelf.

Whether at-home or on the go, the new Spa Calming Cleansing Cloths are 100% plant-based and touted as the brand’s softest cloths yet, said the company.

“As a leader in intimate care, we know that self-care is not only part of a routine, but it can alter how you feel inside and out,” said Jeanne Collins, vice president of marketing at Prestige Consumer Healthcare. “To give consumers an easy avenue to practice daily self-care, we expanded the Spa Collection with new offerings for even more pampering moments at home or on-the-go.”

In 2022, Summer’s Eve celebrated 50 years of business with new packaging. According to the company, the Summer’s Eve portfolio now features a more modern design.

Tarrytown, NY
www.prestigebrands.com

Sales: $320 million

Leading the way at Prestige Brands for Summer 2022 is its intimate care brand Summer’s Eve. The women’s personal care line is tapping into the wellness category with a new Spa collection that includes a wash and a new addition to one’s regimen: an intimate skin serum. Products are now available in food, drug and mass retailers nationwide as well as on Amazon.

Summer’s Eve is tapping into the power of influencers to promote the Summer’s Eve Spa Collection on social media. It kicked off the launch with a party in New York City in May 2022 with its new spokesperson—licensed esthetician and wellness expert Jade Marie.

Summer’s Eve is tapping into the wellness category with a new spa collection that includes a wash and a new addition to one’s regimen—an intimate skin serum.

Sales: $240 million (estimated)
Corporate sales: $943 million

When something is aching, itching or just doesn’t feel quite right, Prestige Consumer Healthcare has an answer. The company’s roster of products includes many well-known personal care and OTC brands like DenTek, Summer’s Eve, Nix, Boudreaux’s Butt Paste, and most recently, TheraTears, a dry eye treatment. Prestige acquired TheraTears and other over-the-counter consumer brands from Akorn Operating Company LLC in a $230 million cash deal announced in May.

Corporate revenues for the year ended March 31, 2021 were $943.4 million, down 2.0% versus 2020. Positively impacted categories benefited from the shift to OTC healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19, according to Prestige. For example, the firm’s North American dermatological segment reported a 3.4% rise in revenue over 2020 and oral care revenues posted a 6.7% gain. On the flip side, Prestige’s cough and cold business in the US, which falls outside of Happi’s main market coverage, recorded a steep 35.9% decline.

Among the new products at Prestige-owned feminine care brand Summer’s Eve is a new Active Chafe gel, billed as a dual-action formula that glides on smoothly and dries to a silky, powder dry feel to protect and relieve chafing and irritation on delicate areas. The lightweight, non-greasy formula can be used on inner thighs, bikini area, under breasts and underarms, according to the company.

Tarrytown, NY
www.prestigebrandsinc.com

Sales: $400 million. Corporate sales: $1.0 billion.

Prestige Brands’ personal care sales surged following the late 2016 acquisition of CB Fleet, the manufacturer of Summer’s Eve and other products. The gains were also due, in part, to the continued strength of the company’s OTC lineup.

Household product sales fell more than 8%, due to continued decline in Comet sales.

Tarrytown, NY
www.prestigebrandsinc.com

Sales: $308 million (estimated) for household and personal care products.

Corporate sales: $882 million.

Prestige Brands has fully integrated its January 2017 acquisition of Fleet Laboratories, including its first manufacturing facility located in Lynchburg, VA. DenTek is continuing to boost business at the company. Reported revenues for the second quarter of fiscal 2017 jumped 4.4% to $215.1 million. Reported revenues for the six-month period ended Sept. 30, 2016 rose 6.6% to $424.6 million. The results, according to the firm, reflect consumption increases across its invest-for-growth portfolio and the addition of the DenTek business.

Prestige Brands also rolled out a major launch for Summer 2017: Summer’s Eve personal care wipes and cleansers in exotic scents such as Mandarin Blossom and Coconut Water.

In more feminine care news, Natureplex—an over-the-counter drug manufacturer headquartered in Olive Branch, MI—has licensed feminine hygiene brand Massengill from Prestige Brands Holdings. Massengill, which has been around since the 1970s, holds the No. 2 position in the category. The company said it plans to work diligently on transitioning customers over in early 2017, as well as working on new products to complement the brand.

Also in 2017, the company’s board elected Ron Lombardi as chairman. Gary E. Costley will remain the company’s lead independent director.

Lombardi, president and CEO, stated, “In fiscal 2018, we expect continued organic growth in our existing business and incremental revenues from the acquisition of Fleet to drive growth.”

Tarrytown, NY
914.524.6800
www.prestigebrands.com

Sales: $210 million (estimated). Corporate sales: $714.6 million.

Fiscal 2015 was a big year for Prestige Brands, as revenues for the period ended March 31, 2015 came in at $714.6 million, an increase of 19.6%.

Revenues for the North American OTC healthcare segment increased 17.5% to $563.5 million. The firm’s Insight acquisition contributed $96.9 million to the segment overall, including a $15.4 million gain from dermatologicals, which was partially offset by declines of $7.1 million incurred by other Prestige-owned dermatological products, the company said.

Revenues for the international OTC healthcare segment increased 104.5%, primarily due to the acquisition of Hydralyte, which contributed gains via gastrointestinal, eye and ear care and cough and cold products. Hydralyte is the leading OTC brand in oral rehydration in Australia, and is now marketed through Prestige’s Care Pharmaceuticals Pty Ltd. subsidiary.

Prestige Brands’ household cleaning segment saw revenues rise 2.5% to $89.9 million.

Sales beyond the borders of North America represented 8.9% of revenues in 2015 compared to 5.4% and 2.7% in 2014 and 2013, respectively. In addition to OTC products such as Clear Eyes, Murine and Chloraseptic that are sold internationally, Prestige Brands has licensed to an international CPG company the right to use the Comet, Spic and Span and Chlorinol trademarks in the commercial/I&I business throughout the world (excluding Russia and specified Eastern European countries).  Comet and Chlorinol brands have been licensed out in different deals.

In personnel moves, Matthew M. Mannelly retired last month and Ron Lombardi took over as CEO.

Tarrytown, NY
914.524.6800
www.prestigebrands.com

Sales: $220 million (estimated) for household and personal care products. Corporate sales: $602 million for the year ended March 31, 2014.

Prestige Brands’ net revenues for the fiscal year ended March 31, 2014 were $601.9 million, a decrease of 3.5% over the prior fiscal year. OTC segment revenues were $513.8 million, a decrease of 4.3%, which the firm said was driven by lower cough/cold incidence levels, the impact of the return of competitive products to the marketplace, and changes in retailer inventory levels. Fiscal 2014 revenues for the household cleaning segment, which represents less than 15% of overall company revenues, rose 1.5% to $88.0 million.

In April, Prestige Brands Holdings, Inc. entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, marketer and distributor of feminine care and other OTC healthcare products, for $750 million in cash. The deal adds Monistat OTC yeast infection treatment and EPT home pregnancy test products and other feminine care brands to Prestige’s portfolio. In addition to giving the company a platform in feminine care in the US and Canada, the Insight acquisition adds other personal care products from Caldesene and Gentle Naturals baby care products to first aid offerings like Nix lice treatment, Caldecort anti-itch cream and Skin Shield liquid bandage to cold and flu products to pain relievers.

Earlier in April, Prestige also acquired Hydralyte, a leading OTC oral rehydration brand sold in Australia and New Zealand.
According to Matthew M. Mannelly, CEO, Monistat will become the company’s first $100 million brand.

“The acquisition is expected to boost Prestige’s annual revenues to approximately $800 million, bringing us closer to our stated goal of becoming a billion dollar OTC products company,” Mannelly said in a statement when the Insight deal was announced.

Tarrytown, NY
914.524.6800
www.prestigebrands.com

Sales: $175 million (estimated) for personal care and household products. Corporate sales: $623.6 million for the year ended March 31, 2013.

The company bills itself as the only independent, publicly-traded OTC company in the US. Corporate sales soared 41.5% primarily due to the growth of revenues of the company’s core OTC brands and a full year of ownership of acquired GSK brands. (In the prior year, the GSK brands contributed revenues for only the final two months of the fiscal year.)

For Prestige Brands, OTC is the future, as its home care business continues to shrink in importance.

For the fiscal year ended March 31, 2013, total revenues from home cleaning were just $86.6 million—just 13.9% of revenues, compared with 21.8% and 30.3% in 2012 and 2011, respectively.

“Our strategies are in place and we are fully prepared to build on the success of fiscal 2013. As the largest independent OTC products company in the US, we are confident in our ability to continue to build brands, innovate within our portfolio, and invest appropriately for future value creation,” said CEO Matthew M. Mannelly.

While OTC remedies may be the sexiest area for Prestige, some of the firm’s existing personal care and home brand hold impressive spots in their categories. For example, according to Prestige Brands, Efferdent Denture Cleanser (which Prestige considers a core brand) holds a 31.6% share and the No. 2 position in the $148 million denture cleanser tablets category, while Chore Boy holds an 11.7% share of the market and a No. 2 position in the Soap Free Metal Scrubbers market.

Meanwhile, New-Skin holds a 63.8% market share and the top position in the $23.4 million Liquid bandages market.

Irvington,NY
914.524.6800
www.prestigebrands.com
Sales: $344 million (estimated) for personal care and household products.
Corporate sales: $441.1 million for the year ended March 31, 2012.

Prestige Brands Holdings, Inc. record results for the fourth quarter and fiscal year ended March 31, 2012, were driven by strong OTC organic growth and the completion of the acquisition of 17 brands from GlaxoSmithKline, which was the largest acquisition in the company’s history. In that deal, Prestige picked up Beano, BC, Goody’s and Debrox in the US and Gaviscon in Canada, products that mainly fall outside of Happi’s scope.

Corporate revenues for fiscal 2012 were $441.1 million, an increase of 31.1% over the prior year’s revenues of $336.5 million. OTC healthcare sales reached $344.2 million and household products coming in at 93.5 million.

Organic revenues for the company grew 3.2% during fiscal 2012 over the prior year comparable period. Revenues from the GSK acquisition accounted for $30.4 million of the increase. Blacksmith Brands and Dramamine contributed $63.5 million of the increase for the period prior to the anniversary of their respective purchases.

Income from continuing operations for fiscal 2012 of $37.2 million was 27.5% higher than fiscal 2011 income from continuing operations of $29.2 million. Income from continuing operations for fiscal 2012 was impacted by $12.9 million of costs primarily associated with the GSK acquisition and costs associated with the evaluation of the Genomma Lab unsolicited proposal. (That’s right; Avon wasn’t the only company with unwanted advances this past year.)

“In less than three years, our clear and consistent value creation strategy has taken hold,” said Matthew M. Mannelly, president and CEO. “We have transformed Prestige into the largest independent OTC products company in the US with a proven ability to generate consistent organic growth in our core OTC business coupled with a leading free cash flow profile,” he said.

According to Mannelly, the firm’s M&A strategy has transformed Prestige into a company with approximately “90% of profits derived from higher growth, higher margin OTC brands.”

Revenues for the household cleaning segment fell 5.7%, during 2012 versus 2011. Comet revenues decreased primarily due to softer consumer consumption of non-abrasive products, however Chore Boy and Spic and Span revenues increased as a result of increased promotional activity, and expanded distribution and consumer demand for Spic and Span sprays and Chore Boy copper scrubbers, the company said.

Prestige Brands’ principal customer relationships include Walmart, Walgreens, CVS, Target and Dollar Tree—and sales to its top five and 10 customers accounted for approximately 40.0% and 50.1% of total gross sales, respectively, in 2012 compared with approximately 41.7% and 53.0%, respectively, in 2011 and approximately 45.6% and 57.3%, respectively, in 2010. No single customer other than Walmart accounted for more than 10% of the firm’s gross sales in any of those years and none of its other top five customers accounted for less than 3% of our gross sales in any of those years. During 2012, 2011 and 2010, Walmart accounted for approximately 18.9%, 20.3% and 24.4%, respectively, of gross revenues.

Irvington, NY

Tel: 914-524-6800

www.prestigebrands.com

Sales: $336 million

Sales:

$336 million. Net income: $29 million for the year ended March 31, 2011.

Venerable brand names in medicated skin care (Compound W, Cloverline) and home care (Spic and Span and Comet) are part of Prestige Brands’ stable, but it is OTC healthcare that drives the firm. This Irvington, NY-based company has been expanding its OTC healthcare roster via acquisitions, which in turn has helped propel revenues by more than 15% this past year.

According to the company, revenues for the fiscal year ended March 31, 2011 topped $336 million, with OTC healthcare unit accounting for the majority of the company’s revenues for the year.Revenues from the household side of Prestige Brands’ business came in at nearly $102 million.

One of its new healthcare pick-ups, Dramamine, accounted for a large percentage of that 15% growth. Organic revenues for the company grew 1.7% during the current year over the prior year, according to Prestige Brands, which saw its income from continuing operations for fiscal 2011 fall 9.0% to was $29.2 million.

In 2010, prestige completed the integration of Blacksmith Brands, including Efferdent and Effergrip denture products.

“(It) has been an extremely productive and transformative year for Prestige Brands,” said Matthew M. Mannelly, president and CEO.

While OTC healthcare is growing for Prestige, household care isn’t faring as well. Revenues for the household cleaning segment for the fourth fiscal quarter fell 8.1% as Comet, Spic and Span and Chore Boy continued to face negative category consumption trends and competitive pressures at retail, the company said.

On the personnel front, Ron Lombardi was named CFO in late 2010 when Pete Anderson retired, and in March 2011, Paul A. Hennessey came over from Pfizer Consumer Healthcare to serve as vice president, operations. While at Pfizer, Hennessey spent 18 years in supply chain and manufacturing operations in positions of increasing responsibility.

Irvington, NY
914.524.6800
www.prestigebrands.com
Sales: $302 million

Sales:
$302 million. Net income: $32 million for the fiscal year ended March 31, 2010.

For its most recently completed fiscal year, Prestige Brands’ household cleaning sales were $108.7 million and its personal care sales were $10.8 million. The firm’s OTC health care products business—which includes remedies such as Little Noses, Compound W and Murine—generated sales of $177 million.

Last fall, the firm sold three shampoo businesses (Denorex, Prell and Zincon) to Ultimark Products. The trio of brands represented approximately 2-3% of Prestige’s company sales. The deal included an upfront payment of $8 million in cash, with a subsequent payment of $1 million that’ s due Oct. 28, 2010. The proceeds from the sale were earmarked to pay down debt.

“The successful sale of these businesses allows us to increase focus on our two larger segments, over-the-counter healthcare and household cleaning products, to enhance shareholder value,” said Matthew Mannelly, Prestige Brands’ president and chief executive officer. Mannelly took over in September when Mark Pettite resigned.

Shampoo wasn’t the only thing Prestige Brands shed; last September it completed of a staff reduction program that eliminated approximately 10% of the company’s workforce.

Irvington, NY
914.524.6800
www.prestigebrands.com
Sales: $312 million

Sales: $312 million. Net loss: $186 million for the year ended March 31, 2009.

Sales fell more than 4% last year. After posting net income of nearly $34 million the previous year, the company reported a net loss in the fourth quarter of $211.1 million. It includes the effects of a non-cash, pre-tax impairment charge of $249.6 million to reduce the book value of the company’s goodwill and other intangible assets to their estimated fair value. Excluding the impairment charge, net income for the quarter would have been $9 million.

The company competes in three categories: health care (56.6% of sales), household care (37.1%)and personal care (6.3%). Sales of health care products fell 3.7%, as gains for Clear Eyes and New-Skin were offset by declines of wart care brands. During the year, this division relaunched Dermoplast poison ivy treatment under the New-Skin brand to leverage the New-Skin name.

Sales of household cleaners fell 4.2% to $116 million. The 2008 introduction of Comet Mildew SprayGel extended the franchise and helped Comet capture a 10% share of the mildew category and increase the brand’s overall revenues. However, that gain was offset by lower sales of Spic and Span and Chore Boy.

Personal care sales fell 9.5% to $19.7 million. Declining sales of all other brands offset increased sales of Cutex.

Third-party manufacturers manufacture all products for Prestige Brands. As of March 31, 2009, the company had relationships with more than 40 third-party manufacturers, with the top 10 accounting for 81% of sales.

Irvington, NY
914-524-6800
www.prestigebrands.com
Sales: $326 million

Sales:

$326.6 million. Net income: $33.9 million.

Sales rose 3%, but net income dropped 6%. Chairman and CEO Mark Pettie said the company is pleased with the results and that the company is on the road to sustainable organic growth. During the year, Prestige Brands management identified the strategic changes necessary to deliver this growth and are implementing them in the new year.

“The key elements of disciplined portfolio management, breakthrough innovation, international growth, and improved organizational effectiveness set the stage for what we anticipate will be improved organic growth performance in the new fiscal year and beyond,” he said.